Inscrição na biblioteca: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Publicou 6 edições por ano

ISSN Imprimir: 0743-4863

ISSN On-line: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Expanding the domain of drug delivery for HIV prevention: exploration of the transdermal route

Volume 34, Edição 6, 2017, pp. 551-587
DOI: 10.1615/CritRevTherDrugCarrierSyst.2017020147
Get accessGet access

RESUMO

Constant efforts for HIV prevention using antiretroviral drugs, pre- and postexposure prophylactic agents, and microbicides are being made by researchers. Drug-delivery systems such as oral tablets and coitally dependent vaginal gels are short acting, require daily application, and are associated with user adherence issues, whereas the coitally independent systems such as injectables and biodegradable implants are long acting, lasting several months, during which time the termination of prophylaxis is impractical in case of adverse effects. An effective drug-delivery system to be used for an intermediate duration, if available, would be an attractive alternative option for users in terms of adherence. Transdermal delivery systems, overcoming most of the limitations of the other routes of administration and aiming to provide sustained delivery of drugs through skin, may be explored for HIV prevention. Passive and physical enhancement techniques may be designed strategically to improve the transdermal delivery of HIV preventive agents.

CITADO POR
  1. Puri Ashana, Bhattaccharjee Sonalika, Zhang Wei, Clark Meredith, Singh Onkar, Doncel Gustavo, Banga Ajay, Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV, Pharmaceutics, 11, 4, 2019. Crossref

  2. Jiang Ying, Gao Xinyi, Singh Onkar N., Zhang Wei, Agrahari Vivek, Peet M. Melissa, Clark Meredith R., Doncel Gustavo F., Banga Ajay K., Pharmacokinetics of a weekly transdermal delivery system of tenofovir alafenamide in hairless rats, International Journal of Pharmaceutics, 582, 2020. Crossref

  3. Shrestha Roman, McCoy-Redd Benjamin, Meyer Jaimie P., HIV pre-exposure prophylaxis for people who inject drugs, in The Opioid Epidemic and Infectious Diseases, 2021. Crossref

  4. Puri Ashana, Frempong Dorcas, Mishra Dhruv, Dogra Prashant, Microneedle-mediated transdermal delivery of naloxone hydrochloride for treatment of opioid overdose, International Journal of Pharmaceutics, 604, 2021. Crossref

  5. Tijani Akeemat O., Nunez Estefany, Singh Karyn, Khanna Garima, Puri Ashana, Transdermal Route: A Viable Option for Systemic Delivery of Antidepressants, Journal of Pharmaceutical Sciences, 110, 9, 2021. Crossref

  6. Tijani Akeemat O., Thakur Divya, Mishra Dhruv, Frempong Dorcas, Chukwunyere Umeh I., Puri Ashana, Delivering therapeutic cannabinoids via skin: Current state and future perspectives, Journal of Controlled Release, 334, 2021. Crossref

  7. Moura Rayssa Barbary Pedroza, Andrade Lígia Marquez, Alonso Lais, Alonso Antonio, Marreto Ricardo Neves, Taveira Stephânia Fleury, Combination of lipid nanoparticles and iontophoresis for enhanced lopinavir skin permeation: Impact of electric current on lipid dynamics, European Journal of Pharmaceutical Sciences, 168, 2022. Crossref

  8. Holman Miranda Kay, Brown Stacy D, Frempong Dorcas, Puri Ashana, Dinh Steven, Cagliero Cecilia, Development and Validation of a Liquid Chromatography-Mass Spectrometry Assay for Determination of Cromolyn Sodium in Skin Permeation Studies, Journal of Analytical Methods in Chemistry, 2022, 2022. Crossref

Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa Políticas de preços e assinaturas Begell House Contato Language English 中文 Русский Português German French Spain